We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+10.8%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$433B
AUM Growth
+$39.3B
Cap. Flow
+$6.99B
Cap. Flow %
1.61%
Top 10 Hldgs %
19.86%
Holding
3,573
New
35
Increased
2,384
Reduced
635
Closed
102

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$2.16B
2
HSY icon
Hershey
HSY
+$663M
3
LMT icon
Lockheed Martin
LMT
+$622M
4
MO icon
Altria Group
MO
+$525M
5
PFE icon
Pfizer
PFE
+$499M

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$2.76B
2
MRK icon
Merck
MRK
+$2.35B
3
ADP icon
Automatic Data Processing
ADP
+$1.57B
4
BX icon
Blackstone
BX
+$1.38B
5
ITW icon
Illinois Tool Works
ITW
+$1.13B

Sector Composition

Rank Sector Weight
1 Technology 22.85%
2 Financials 12.71%
3 Healthcare 11.72%
4 Consumer Discretionary 10.09%
5 Industrials 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTRX icon
3276
Matrix Service
MTRX
$326M
$141K ﹤0.01%
10,847
VCSA
3277
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
$141K ﹤0.01%
20,667
-12,080
-37% -$98.5K
CARM
3278
DELISTED
Carisma Therapeutics
CARM
$138K ﹤0.01%
60,952
-11,791
-16% -$28.3K
ORGN
3279
DELISTED
Origin Materials
ORGN
$138K ﹤0.01%
9,021
SLDB icon
3280
Solid Biosciences
SLDB
$794M
$137K ﹤0.01%
+10,276
New +$96.2K
ORN icon
3281
Orion Group Holdings
ORN
$396M
$137K ﹤0.01%
16,674
NNBR icon
3282
NN Inc
NNBR
$255M
$135K ﹤0.01%
28,401
VSTM icon
3283
Verastem
VSTM
$510M
$132K ﹤0.01%
+11,159
New +$129K
GOCO
3284
DELISTED
GoHealth
GOCO
$129K ﹤0.01%
12,272
XAIR icon
3285
Beyond Air
XAIR
$3.8M
$127K ﹤0.01%
182
AKTS
3286
DELISTED
Akoustis Technologies Inc
AKTS
$126K ﹤0.01%
213,442
+55,550
+35% +$35.9K
MKTW icon
3287
MarketWise
MKTW
$52.5M
$125K ﹤0.01%
3,621
RDW icon
3288
Redwire
RDW
$2.06B
$124K ﹤0.01%
28,228
AFRI icon
3289
Forafric Global
AFRI
$289M
$124K ﹤0.01%
11,937
VTGN icon
3290
VistaGen Therapeutics
VTGN
$9.89M
$123K ﹤0.01%
23,302
IMA
3291
ImageneBio Inc
IMA
$63M
$122K ﹤0.01%
7,162
UHG
3292
DELISTED
United Homes Group
UHG
$122K ﹤0.01%
17,396
CMBM
3293
DELISTED
Cambium Networks
CMBM
$121K ﹤0.01%
27,989
FEAM icon
3294
5E Advanced Materials
FEAM
$45.7M
$120K ﹤0.01%
3,908
HNST icon
3295
The Honest Company
HNST
$402M
$119K ﹤0.01%
29,467
-13,500
-31% -$45.5K
FOSL icon
3296
Fossil Group
FOSL
$293M
$113K ﹤0.01%
110,605
-2,577,079
-96% -$2.88M
NOTV
3297
DELISTED
Inotiv
NOTV
$109K ﹤0.01%
+10,000
New +$59.8K
SERA icon
3298
Sera Prognostics
SERA
$79.9M
$109K ﹤0.01%
12,000
BRBS icon
3299
Blue Ridge Bankshares
BRBS
$315M
$109K ﹤0.01%
40,458
-5,502
-12% -$15K
PIII icon
3300
P3 Health Partners
PIII
$32.7M
$108K ﹤0.01%
2,095

Similar funds

Charles Schwab's Q1 2024 Portfolio in Review

As of Q1 2024, Charles Schwab held 3,573 positions worth $433B, up 10% from $394B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Trading was light in Q1 2024: portfolio turnover was 3.8%. Charles Schwab opened 35 new positions and exited 102, leaving the 3,573-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q1 2024 buy was Schwab Fundamental US Large Company Index ETF: 3,608,604 shares worth $81.1M.
  • Charles Schwab added most to Bristol-Myers Squibb in Q1 2024, an estimated $2.16B increase.
  • Charles Schwab's biggest Q1 2024 reduction was Broadcom, cutting an estimated $2.76B.
  • Charles Schwab fully exited Splunk Inc in Q1 2024, selling an estimated $104M.
  • Charles Schwab's ten largest holdings make up 20% of its $433B portfolio in Q1 2024.
  • Charles Schwab opened 35 new positions and closed 102 in Q1 2024.
  • Charles Schwab's portfolio value rose 10% quarter-over-quarter to $433B.

Based on Charles Schwab's 13F filing for Q1 2024, filed 9 May 2024.